AAAAAA

   
Results: 1-17 |
Results: 17
Identification of polymorphisms in the 5 '-untranslated region of the TAFIgene: relationship with plasma TAFI levels and risk of venous thrombosis
Authors: Franco, RF Fagundes, MG Meijers, JCM Reitsma, PH Lourenco, D Morelli, V Maffei, FH Ferrari, IC Piccinato, CE Silva, WA Zago, MA
Citation: Rf. Franco et al., Identification of polymorphisms in the 5 '-untranslated region of the TAFIgene: relationship with plasma TAFI levels and risk of venous thrombosis, HAEMATOLOG, 86(5), 2001, pp. 510-517
Genetic risk factors of venous thrombosis
Authors: Franco, RF Reitsma, PH
Citation: Rf. Franco et Ph. Reitsma, Genetic risk factors of venous thrombosis, HUM GENET, 109(4), 2001, pp. 369-384
Factor XIII Val34Leu and the risk of myocardial infarction
Authors: Franco, RF Pazin, A Tavella, MH Simoes, MV Marin-Neto, JA Zago, MA
Citation: Rf. Franco et al., Factor XIII Val34Leu and the risk of myocardial infarction, HAEMATOLOG, 85(1), 2000, pp. 67-71
Ethnic heterogeneity of the factor XIII Val34Leu polymorphism
Authors: Attie-Castro, FA Zago, MA Lavinha, J Elion, J Rodriguez-Delfin, L Guerreiro, JF Franco, RF
Citation: Fa. Attie-castro et al., Ethnic heterogeneity of the factor XIII Val34Leu polymorphism, THROMB HAEM, 84(4), 2000, pp. 601-603
HFE gene mutations in coronary atherothrombotic disease
Authors: Calado, RT Franco, RF Pazin, A Simoes, MV Marin-Neto, JA Zago, MA
Citation: Rt. Calado et al., HFE gene mutations in coronary atherothrombotic disease, BRAZ J MED, 33(3), 2000, pp. 301-306
Gene polymorphisms in the TNF locus and the risk of myocardial infarction
Authors: Padovani, JC Pazin, A Simoes, MV Marin-Neto, JA Zago, MA Franco, RF
Citation: Jc. Padovani et al., Gene polymorphisms in the TNF locus and the risk of myocardial infarction, THROMB RES, 100(4), 2000, pp. 263-269
Factor XIII Va134Leu and the risk of venous thromboembolism in factor V Leiden carriers
Authors: Franco, RF Middeldorp, S Meinardi, JR van Pampus, ECM Reitsma, PH
Citation: Rf. Franco et al., Factor XIII Va134Leu and the risk of venous thromboembolism in factor V Leiden carriers, BR J HAEM, 111(1), 2000, pp. 118-121
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Authors: Franco, RF de Jonge, E Dekkers, PEP Timmerman, JJ Spek, CA van Deventer, SJH van Deursen, P van Kerkhoff, L van Gemen, B ten Cate, H van der Poll, T Reitsma, PH
Citation: Rf. Franco et al., The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation, BLOOD, 96(2), 2000, pp. 554-559
Porphyria cutanea tarda in Brazilian patients: Association with hemochromatosis C282Y mutation and hepatitis C virus infection
Authors: Martinelli, ALC Zago, MA Roselino, AMF Filho, AB Villanova, MG Secaf, M Tavella, MH Ramalho, LNZ Zucoloto, S Franco, RF
Citation: Alc. Martinelli et al., Porphyria cutanea tarda in Brazilian patients: Association with hemochromatosis C282Y mutation and hepatitis C virus infection, AM J GASTRO, 95(12), 2000, pp. 3516-3521
Heterogeneous ethnic distribution of the factor V Leiden mutation
Authors: Franco, RF Elion, J Santos, SEB Araujo, AG Tavella, MH Zago, MA
Citation: Rf. Franco et al., Heterogeneous ethnic distribution of the factor V Leiden mutation, GENET MOL B, 22(2), 1999, pp. 143-145
Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis
Authors: Franco, RF Reitsma, PH Lourenco, D Maffei, FH Morelli, V Tavella, MH Araujo, AG Piccinato, CE Zago, MA
Citation: Rf. Franco et al., Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis, THROMB HAEM, 81(5), 1999, pp. 676-679
The prevalence of factor V Arg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in different human populations
Authors: Franco, RF Elion, J Tavella, MH Santos, SEB Zago, MA
Citation: Rf. Franco et al., The prevalence of factor V Arg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in different human populations, THROMB HAEM, 81(2), 1999, pp. 312-313
Factor V Leiden and factor II G20210A mutations in patients with recurrentabortion
Authors: Souza, SS Ferriani, RA Pontes, AG Zago, MA Franco, RF
Citation: Ss. Souza et al., Factor V Leiden and factor II G20210A mutations in patients with recurrentabortion, HUM REPR, 14(10), 1999, pp. 2448-2450
A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease
Authors: Franco, RF Morelli, V Lourenco, D Maffei, FH Tavella, MH Piccinato, CE Thomazini, IA Zago, MA
Citation: Rf. Franco et al., A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease, BR J HAEM, 105(2), 1999, pp. 556-559
The 20210 G -> A mutation in the 3 '-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease
Authors: Franco, RF Trip, MD ten Cate, H van den Ende, A Prins, MH Kastelein, JJP Reitsma, PH
Citation: Rf. Franco et al., The 20210 G -> A mutation in the 3 '-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease, BR J HAEM, 104(1), 1999, pp. 50-54
Are haemochromatosis mutations related to the severity of liver disease inhepatitis C virus infection?
Authors: Martinelli, ALC Franco, RF Villanova, MG Figueiredo, JFC Secaf, M Tavella, MH Ramalho, LNZ Zucoloto, S Zago, MA
Citation: Alc. Martinelli et al., Are haemochromatosis mutations related to the severity of liver disease inhepatitis C virus infection?, ACT HAEMAT, 102(3), 1999, pp. 152-156
Factor VArg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in venous thrombotic disease
Authors: Franco, RF Maffei, FH Lourenco, D Morelli, V Thomazini, IA Piccinato, CE Tavella, MH Zago, MA
Citation: Rf. Franco et al., Factor VArg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in venous thrombotic disease, BR J HAEM, 103(3), 1998, pp. 888-890
Risultati: 1-17 |